Accenture Soars 17% Premarket as Alphabet, Rocket Lab Also Gain

2 min read
Accenture Soars 17% Premarket as Alphabet, Rocket Lab Also Gain
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

Accenture jumped 17% premarket after beating fiscal fourth-quarter estimates, while Alphabet, Rocket Lab and McCormick also posted sharp gains ahead of the open. Micron beat profit and revenue forecasts but slipped slightly, even as other chip names advanced.

Accenture and McCormick beat estimates

Accenture led premarket gains, rising 17% after its fiscal fourth-quarter revenue of $18.68 billion topped the company's own guidance of $17.75 billion to $18.4 billion and FactSet's consensus estimate of $18.3 billion. Its earnings of $3.29 per share also beat expectations.

McCormick shares climbed nearly 5% after its third-quarter adjusted earnings came in at 86 cents per share, above the 76 cents analysts polled by FactSet had expected. Revenue reached $2.02 billion against a $1.98 billion consensus.

Alphabet gains on new AI model, Rocket Lab on launch deal

Alphabet moved 2% higher after unveiling Gemini 4 Argon, which the company said delivers improvements in cybersecurity, coding and complex professional work.

Rocket Lab shares rose 4.5% after signing a multiyear launch agreement for 20 new Electron missions with Tokyo-based Synspective, a deal the company said is its largest commercial launch contract for Electron to date.

Nu Holdings added nearly 6% after the Brazilian digital bank denied it is pursuing a transaction with U.K. digital bank Monzo, saying it was responding to media speculation about a potential acquisition.

Micron reported an adjusted $33.42 per share on revenue of $54.23 billion for its fiscal fourth quarter, ahead of the $31.61 per share and $51.07 billion revenue analysts polled by LSEG had expected. The stock fell slightly despite the results, though the Roundhill Memory ETF (DRAM) gained more than 1%, while the VanEck Semiconductor ETF (SMH) advanced 1%.

Source: US Top News and Analysis

Trading involves risk.

Most traded markets

XAU / USD
+0.01% 4,157.33
BRENT
+3.29% 104.938
BTC / USD
-0.79% 83,684.1
EUR / USD
-0.31% 1.12935
USTEC
-0.34% 30,353.60
AAPL
-1.58% 328.69
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Indices News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.